Shorter survival of SDF1-3' A/3' A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 311-315

  Brambilla, Andrea ^a,i   Villa, Chiara ^a   Rizzardi, GianPaolo ^c   Veglia, Fabrizio ^b   Ghezzi, Silvia ^a   Lazzarin, Adriano ^b   Cusini, Marco ^d   Muratori, Simona ^d   Santagostino, Elena ^e   Gringeri, Alessandro ^e   Louie, Leslie G ^f   Sheppard, Haynes W ^g   Poli, Guido ^a   Michael, Nelson L ^h   Pantaleo, Giuseppe ^c   Vicenzi, Elisa ^a,j  

^a AIDS Immunopathogenesis Unit   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d STD Clinic   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^h WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

ⁱ BAYER Pharmacological Research   (Italy)

^j P2 P3 Laboratories   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ALLELISM; ARTICLE; CELL SURVIVAL; DISEASE COURSE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; CHEMOKINES, CXC; COHORT STUDIES; CRESOLS; DISEASE PROGRESSION; DRUG COMBINATIONS; FORMALDEHYDE; GENETIC MARKERS; GENOTYPE; HIV-1; HUMANS; MALE; POLYMORPHISM, GENETIC; PROGNOSIS; RESORCINOLS; SURVIVAL RATE; VIREMIA;

EID: 0033930343     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315650     Document Type: Article

References (16)

1. 1. Michael NL. Host genetic influences on HIV-1 pathogenesis. Curr Opin Immunol 1999;11:466-74.
2. 2. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant: ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-93.
3. 3. Mummidi S, Ahuja SS, Gonzalez E, et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998;4:786-93.
4. 4. van Rij RP, Broersen S, Goudsmit J, Coutinho RA, Schuitemaker H. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection. AIDS 1998;12:F85-90.
5. 5. Anonymous. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
6. 6. Michael NL, Louie LG, Rohrbaugh AL, et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 1997;3:1160-2.
7. 7. Morawetz RA, Rizzardi GP, Glauser D, et al. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression: Swiss HIV Cohort. Eur J Immunol 1997;27:3223-7.
8. 8. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997;3:338-40.
9. 9. Vicenzi E, Bagnarelli P, Santagostino E, et al. Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood 1997;89:191-200.
10. 10. Rizzardi GP, Morawetz RA, Vicenzi E, et al. CCR2 polymorphism and HIV disease: Swiss HIV Cohort. Nat Med 1998;4:252-3.
11. 11. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res 1993;21:3761-6.
12. 12. Ioannidis JP, O'Brien TR, Rosenberg PS, Contopoulos-Ioannidis DG, Goedert JJ. Genetic effects on HIV disease progression. Nat Med 1998; 4:536.
13. 13. Gonzalez E, Bamshad M, Sato N, et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA 1999;96:12004-9.
14. 14. van Rij RP, de Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis 1998;178:1806-11.
15. 15. Balotta C, Bagnarelli P, Corvasce S, et al. Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. J Infect Dis 1999;180:285-9.
16. 16. Aziz N, Nishanian P, Taylor JM, et al. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. J Infect Dis 1999;179:843-8.